Kura Oncology

Showing 1 posts of 1 posts found.

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023
Medical Communications Kura Oncology, NSCLC, Oncology, oncology

Kura Oncology has shared positive preclinical data which supports the development of its next-generation farnesyl transferase inhibitor (FTI) KO-2806 in …

Latest content